He Xun Investment Advisor Fang Rongxia: Opening Low, Testing Bottom, and Bouncing Back—Is It a Bull Trap or Bargain Hunting?

robot
Abstract generation in progress

Will it fall again tomorrow? Will it go up or down tomorrow? Three signals are very important.

Hedong Investment Advisor Fang Rongxia analyzed that yesterday’s prediction for today’s A-shares was a slight opening lower, followed by oscillation and a pullback, then a rebound. If today’s A-shares are following this script, the key question is what to do tomorrow. Will it rise or fall? It depends on three key signals.

First, the Shanghai Composite Index fell to the 60-day moving average today, holding the first technical line of defense. This confirms its effectiveness, and the short-term downside space is limited.

Second, the 60-minute chart of the Sci-Tech Innovation Board 50 Index shows a bullish divergence signal. As a tech sector indicator, this is a positive sign, indicating that the downward momentum in the tech sector is weakening.

Third, on the capital side, trading volume has mildly decreased, indicating that the market is still dominated by stockholder competition. Funds have withdrawn from previously hot cyclical sectors and flowed into more stable sectors like liquor and semiconductors, showing clear signs of rotation. In this rotation pattern, chasing high is very risky, and it’s more suitable to buy on dips.

Therefore, my clear view is that the resistance from the daily divergence top still exists. The index is unlikely to quickly reverse its downward trend in the short term. Tomorrow is likely to see a continued decline followed by an attempt to stabilize, but upward recovery requires volume to increase in tandem.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments